Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California

Gynecologic Oncology

Volumn 95, Issue 1, 2004, Pages 215-225

  Mills, Paul K ^a,b,d   Riordan, Deborah G ^b   Cress, Rosemary D ^c  

^a Public Health Institute   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PUBLIC HEALTH INSTITUTE   (United States)

^d 1320 East Shaw Avenue   (United States)

Author keywords

Epidemiology; Gynecologic cancer; Tumor classifications

Indexed keywords

HORMONE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER REGISTRY; CANCER RISK; CELL TYPE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ETHNOLOGY; FAMILY HISTORY; FEMALE; HISTOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OVARY CANCER; PARITY; PRIORITY JOURNAL; REPRODUCTION; RISK FACTOR; TELEPHONE TELEMETRY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CALIFORNIA; CASE-CONTROL STUDIES; EPITHELIAL CELLS; FEMALE; HUMANS; LIFE STYLE; MIDDLE AGED; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PARITY; RISK FACTORS;

EID: 4644247720     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.07.012     Document Type: Article

References (59)

1. P.J. Mink, M.E. Sherman, and S.S. Devesa Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978â€"1998 Cancer 95 11 2002 2380 2389
2. L.A.G. Ries, M.P. Eisner, C.L. Kosary, B.F. Hankey, B.A. Miller, and L. Clegg SEER cancer statistics review, 1973â€"1999 2002 National Cancer Institute Bethesda (MD) Available at: http://seer.cancer.gov/csr/ 1973_1999/. Retrieved December 5, 2002
3. M.T. Goodman, H.L. Howe, K.H. Tung, J. Hotes, B.A. Miller, and S.S. Coughlin Incidence of ovarian cancer by race and ethnicity in the United States, 1992â€"1997 Cancer 97 10 2003 2676 2685
4. M.T. Goodman, and H.L. Howe Descriptive epidemiology of ovarian cancer in the United States, 1992â€"1997 Cancer 97 10 2003 2615 2630
5. J.V. Lacey, J. Lubin, M. Sherman, A. Schatzkin, P. Mink, and P. Harte Menopausal hormone replacement therapy and risk of ovarian cancer in a prospective study JAMA 288 2002 334 341
6. W.B. Chapman Developments in the pathology of ovarian tumours Curr. Opin. Obstet. Gynecol. 13 2001 53 59
7. M. Dietal, and S. Hauptmann Serous tumors of low malignant potential of the ovary: 1. Diagnostic pathology Virchows Arch. 436 2000 403 412
8. S. Manek, and M. Wells Pathology of borderline ovarian tumours Clin. Oncol. 11 1999 73 77
9. J.D. Siedman, and R.J. Kurman Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators Hum. Pathol. 31 2000 539 557
10. A. Green, D. Purdie, C. Bain, V. Siskind, and P.M. Webb Cigarette smoking and risk of epithelial ovarian cancer (Australia) Cancer Causes Control 12 2001 713 719
11. B.L. Harlow, N.S. Weiss, G.J. Roth, J. Chu, and J.R. Daling Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones Cancer Res. 48 1988 5849 5852
12. R. Harris, A. Whittemore, J. Itnyre Collaborative Ovarian Cancer Group Characteristics relating to ovarian cancer risk: collaborative analysis of 12 case- control studies. III. Epithelial tumors of low malignant potential in white women Am. J. Epidemiol. 136 1992 1204 1211
13. H. Kuper, D.W. Cramer, and L. Titus-Ernstoff Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status Cancer Causes Control 13 2002 455 463
14. F. Modugno, R.B. Ness, and J.E. Wheeler Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness Ann. Epidemiol. 11 2001 568 574
15. T. Riman, P.W. Dickman, S. Nilsson, N. Correia, H. Nordlinder, C.M. Magnusson, and I.R. Persson Risk factors for invasive epithelial ovarian cancer: results from a Swedish case-control study Am. J. Epidemiol. 156 2002 363 373
16. T. Riman, P.W. Dickman, S. Nilsson, N. Correia, H. Nordlinder, and C.M. Magnusson Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study Gynecol. Oncol. 83 2001 575 585
17. H.A. Risch, L.D. Marrett, M. Jain, and G.R. Howe Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study Am. J. Epidemiol. 144 1996 363 372
18. V. Siskind, A. Green, C. Bain, and D. Purdie Beyond ovulation: oral contraceptives and epithelial ovarian cancer Epidemiology 11 2000 106 110
19. L. Titus-Ernstoff, K. Perez, D.W. Cramer, B.L. Harlow, J.A. Baron, and E.R. Greenberg Menstrual and reproductive factors in relation to ovarian cancer risk Br. J. Cancer 84 5 2001 714 721
20. D.W. Cramer, G.B. Hutchinson, W.R. Welch, R.E. Scully, and K.J. Ryan Determinants of ovarian cancer risk. I. Reproductive experiences and family history J. Natl. Cancer Inst. 71 1983 711 716
21. P.A. Marchbanks, H. Wilson, E. Bastos, D.W. Cramer, J.M. Schildkraut, and H.B. Peterson Cigarette smoking and epithelial ovarian cancer by histologic type Obstet. Gynecol. 95 2000 255 260
22. D.M. Purdie, V. Siskind, C.J. Bain, P.M. Webb, and A.C. Green Reproduction-related risk factors for mucinous and nonmucinous epithelial ovarian cancer Am. J. Epidemiol. 153 9 2001 860 864
23. WHO Collaborative Study of Neoplasia and Steroid Contraceptives Epithelial ovarian cancer and combined oral contraceptives Int. J. Epidemiol. 18 1989 538 545
24. L. Wittenberg, L. Cook, M. Rossing, and N. Weiss Reproductive risk factors for mucinous and non-mucinous epithelial ovarian cancer Epidemiology 10 1999 761 776
25. State of California, Dept. of Finance, Table D-21: Median Income and Poverty Status, 2000 census. Sacramento, CA, December 2002. Available at: http//www.dof.ca.gov/html/fs%5Fdata/stat%2Dabs/TABLES/D21.xls. Retrieved January 12, 2003.
26. P.K. Mills Cancer incidence and mortality in the Central Valley, 1988â€"1997 2000 (March) Cancer Registry of Central California Fresno (CA) Region 2
27. R.D. Cress, C. Creech, and V. Caggiano Cancer incidence in the Sacramento Region, 1988â€"1997 2000 (February) Cancer Surveillance Program Sacramento (CA) Region 3
28. A. Ferrier Mullerian epithelial and mesenchymal tumorsâ€" Introduction, clinical perspective, and principles of management R.P. Farnsworth Surgical pathology of the ovary second ed. 1997 Churchill Livingstone New York (NY) 229 238
29. S.J. Robboy, M.A. Duggan, and R.J. Kurman The female reproductive system E.R. Rubin J.F. Farber Pathology third ed. 1999 Lippincott-Raven Philadelphia 962 1026
30. Y. Katsube, J.W. Berg, and S.G. Silverberg Epidemiologic pathology of ovarian tumors: a histopathologic review of primary ovarian neoplasms diagnosed in the Denver Standard Metropolitan Statistical Area, 1 July-31 December 1969 and 1 July-31 December 1979 Int. J. Gynecol. Pathol. 1 1 1982 3 16
31. O. Miettinen Individual matching with multiple controls in the case of all-or-none responses Biometrics 22 1969 339 355
32. N. Mantel, and W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J. Natl. Cancer Inst. 22 1959 719 748
33. N.E. Breslow, and N.E. Day Statistical methods in cancer research The Analysis of Case-Control Studies vol. 1 1980 International Agency for Research on Cancer Lyon, France
34. N. Mantel Chi square tests with one degree of freedom. Extensions of the Mantelâ€"Haenszel procedure J. Am. Stat. Assoc. 58 1963 690 700
35. D.M. Purdie, C.J. Bain, P.M. Webb, D.C. Whiteman, and S. Pirozzo Body size and ovarian cancer: case-control study and systematic review (Australia) Cancer Causes Control 12 2001 855 863
36. C.I. Perkins, R. Cohen, J.L. Young, R. Schlag, and W.E. Wright Cancer in California: detailed site and histology, 1990â€"1994 1997 (December) California Dept. of Health Services, Cancer Surveillance Section Sacramento (CA)
37. T. Riman, I. Persson, and S. Nilsson Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence Clin. Endocrinol. (Oxf.) 49 1998 695 707
38. D.M. Purdie, P.M. Webb, V. Siskind, C.J. Bain, and A.C. Green The different etiologies of mucinous and nonmucinous epithelial ovarian cancers Gynecol. Oncol. 88 2003 S145 S148
39. K.-H. Tung, M.T. Goodman, A.H. Wu, K. McDuffie, L.R. Wilkens, and L.N. Kolonel Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study Am. J. Epidemiol. 158 2003 629 638
40. Q.J. Wu, M. Guo, Z.M. Lu, T. Li, H.Z. Qiao, and Y. Ke Detection of human papillomavirus-16 in ovarian malignancy Br. J. Cancer 89 4 2003 672 675
41. F. Modugno, R.B. Ness, and C.M. Cottreau Cigarette smoking and the risk of mucinous and nonmucinous epithelial ovarian cancer Epidemiology 13 2002 467 471
42. R.B. Ness, J.A. Grisso, J. Klapper, J.J. Schlesselman, S. Silberzweig, R. Vergona the SHARE Study Group Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives Am. J. Epidemiol. 152 2000 233 241
43. R.B. Ness, D.W. Cramer, M.T. Goodman, S.K. Kjaer, K. Mallin, and B.J. Mosgaard Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies Am. J. Epidemiol. 155 2002 217 224
44. A. Lukanova, P. Toniolo, and E. Lundin Body mass index in relation to ovarian cancer: a multi-centre nested case-control study Int. J. Cancer 99 2002 603 608
45. H.A. Risch Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterones J. Natl. Cancer Inst. 90 1998 1774 1786
46. G.H. Eltabbakh, M.S. Natarajan, M.S. Piver, and C.J. Mettlin Epidemiologic differences between women with borderline ovarian tumors and women with epithelial ovarian cancer Gynecol. Oncol. 74 1999 103 107
47. A.S. Whittemore, R. Harris, J. Itnyre Collaborative Ovarian Cancer Group Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US Case-control Studies. II. Invasive epithelial ovarian cancers in White women Am. J. Epidemiol. 36 1992 1184 1203
48. C. Bosetti, E. Negri, D. Trichopoulos, S. Franceschi, V. Beral, and A. Tzonou Long-term effects of oral contraceptives on ovarian cancer risk Int. J. Cancer 102 2002 262 265
49. P.P. Garg, K. Kerlikowske, L. Subak, and D. Grady Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis Obstet. Gynecol. 2 1998 472 479
50. T. Riman, P.W. Dickman, S. Nilsson, N. Correia, H. Nordlinder, and C.M. Magnusson Hormone replacement therapy and risk of invasive epithelial ovarian cancer in Swedish women J. Natl. Cancer Inst. 94 7 2002 497 504
51. H.A. Risch Hormone replacement therapy and the risk of ovarian cancer Gynecol. Oncol. 86 2002 115 117
52. D.M. Purdie, C.J. Bain, V. Siskind, P. Russell, N.F. Hacker, and B.G. Ward Hormone replacement therapy and risk of epithelial ovarian cancer Br. J. Cancer 81 3 1999 559 563
53. H.A. Risch Estrogen replacement therapy and risk of epithelial ovarian cancer Gynecol. Oncol. 63 1996 254 257
54. N.S. Weiss, J.L. Lyon, S. Krishnamurthy, S.E. Dietert, J.M. Liff, and J.R. Daling Noncontraceptive estrogen use and the occurrence of ovarian cancer J. Natl. Cancer Inst. 68 1 1982 95 98
55. S.L. Kwong, C. Perkins, C.R. Morris, R. Cohen, M. Allen, and W. Wright Cancer in California, 1988â€"1999 2001 (December) California Dept. of Health Services, Cancer Surveillance Section Sacramento (CA)
56. J. Waksberg Sampling methods for random digit dialing J. Am. Stat. Assoc. 73 1978 40 46
57. C. Lele, E.A. Holly, D.S. Roseman, and D.B. Thomas Comparison of control subjects recruited by random digit dialing and area survey Am. J. Epidemiol. 40 7 1994 643 648
58. W. Cozen, R. Peters, J.K.V. Reichardt, W. Ng, J.C. Felix, and P. Wan Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States) Cancer Causes Control 13 2002 113 120
59. California Health Interview Survey CHIS 2001 adult public use file, release 2 [computer file] 2002 (July) UCLA Center for Health Policy Research Los Angeles (CA)